Imaging analytics leader closes $30M round led by Temasek, along with Varian, Northwell Health Ventures, NewYork-Presbyterian, GE Ventures and several leading venture investors
- Two year study* found that clinicians' use of Azurion enabled significant reductions in procedure time, in-lab patient preparation time, post-procedure lab time and enhanced staff experience
Sage is Mach7's third generation platform that enables an ecosystem of apps that simplifies the consolidation, replacement, and adoption of technology that enhance clinical outcomes.
